Stephen Caddick joined Wellcome in June 2015 as Director of the Innovations Division. Previously, he was Vice Provost (Enterprise & London) and Vernon Professor of Organic Chemistry and Chemical Biology at University College London. He is co-founder of Synthetic Pages, an open access website, and Thiologics, an antibody-drug conjugate (ADC) biotech spinout company. His laboratory focuses on chemical modification of proteins and antibodies for development of therapeutics and diagnostics. He has played an important role in the development of the chemical biology strategy and facilities within the Francis Crick Institute.